RenovoRx Ownership 2024 | Who Owns RenovoRx Now?
Institutional Ownership
1.69%
Insider Ownership
1.90%
Retail Ownership
96.41%
Institutional Holders
4.00
RenovoRx Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ADAR1 CAPITAL MANAGEMENT, LLC | 2.38% | 0.08% | 355,240 | 355,240 | 100.00% | 401,421 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.96% | - | 143,919 | 76,831 | 114.52% | 162,651 | Jun 30, 2024 |
NIXON PEABODY TRUST CO | 0.65% | 0.01% | 97,165 | - | - | 109,796 | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | 0.58% | - | 86,316 | 86,316 | 100.00% | 97,537 | Jun 30, 2024 |
VANGUARD GROUP INC | 0.38% | - | 56,737 | - | - | 64,113 | Jun 30, 2024 |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.33% | - | 49,232 | - | - | 55,632 | Jun 30, 2024 |
STATE STREET CORP | 0.17% | - | 26,152 | 7,300 | 38.72% | 29,552,000 | Jun 30, 2024 |
AFFINITY CAPITAL ADVISORS, LLC | 0.09% | 0.00% | 13,279 | - | - | 15,005 | Jun 30, 2024 |
HRT FINANCIAL LP | 0.08% | 0.00% | 11,743 | 11,743 | 100.00% | 13,000 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.07% | - | 10,000 | 10,000 | 100.00% | 11,300 | Jun 30, 2024 |
BLACKROCK INC. | 0.06% | - | 9,162 | -11,678 | -56.04% | 10,353 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.05% | 0.00% | 7,389 | 1,120 | 17.87% | 8,350 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 1,305 | 1,305 | 100.00% | 1,475 | Jun 30, 2024 |
FAMILY FIRM, INC. | 0.01% | 0.00% | 1,000 | 1,000 | 100.00% | 1,130 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 182 | 182 | 100.00% | 206 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -69 | -100.00% | - | Jun 30, 2024 |
RenovoRx's largest institutional shareholder is ADAR1 CAPITAL MANAGEMENT, LLC, holding 2.38% of the company's total share outstanding, currently valued at $401.42K. The top 10 institutional shareholders own together 5.69% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ADAR1 CAPITAL MANAGEMENT, LLC | 2.38% | 0.08% | 355,240 | 355,240 | 100.00% | 401,421 | Jun 30, 2024 |
NIXON PEABODY TRUST CO | 0.65% | 0.01% | 97,165 | - | - | 109,796 | Jun 30, 2024 |
AFFINITY CAPITAL ADVISORS, LLC | 0.09% | 0.00% | 13,279 | - | - | 15,005 | Jun 30, 2024 |
FAMILY FIRM, INC. | 0.01% | 0.00% | 1,000 | 1,000 | 100.00% | 1,130 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.05% | 0.00% | 7,389 | 1,120 | 17.87% | 8,350 | Jun 30, 2024 |
HRT FINANCIAL LP | 0.08% | 0.00% | 11,743 | 11,743 | 100.00% | 13,000 | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | 0.58% | - | 86,316 | 86,316 | 100.00% | 97,537 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.07% | - | 10,000 | 10,000 | 100.00% | 11,300 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.96% | - | 143,919 | 76,831 | 114.52% | 162,651 | Jun 30, 2024 |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.33% | - | 49,232 | - | - | 55,632 | Jun 30, 2024 |
STATE STREET CORP | 0.17% | - | 26,152 | 7,300 | 38.72% | 29,552,000 | Jun 30, 2024 |
VANGUARD GROUP INC | 0.38% | - | 56,737 | - | - | 64,113 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 1,305 | 1,305 | 100.00% | 1,475 | Jun 30, 2024 |
BLACKROCK INC. | 0.06% | - | 9,162 | -11,678 | -56.04% | 10,353 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 182 | 182 | 100.00% | 206 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -69 | -100.00% | - | Jun 30, 2024 |
The largest RenovoRx shareholder by % of total assets is ADAR1 CAPITAL MANAGEMENT, LLC. The company owns 355.24K shares of RenovoRx (RNXT), representing 0.08% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ADAR1 CAPITAL MANAGEMENT, LLC | 2.38% | 0.08% | 355,240 | 355,240 | 100.00% | 401,421 | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | 0.58% | - | 86,316 | 86,316 | 100.00% | 97,537 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.96% | - | 143,919 | 76,831 | 114.52% | 162,651 | Jun 30, 2024 |
HRT FINANCIAL LP | 0.08% | 0.00% | 11,743 | 11,743 | 100.00% | 13,000 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.07% | - | 10,000 | 10,000 | 100.00% | 11,300 | Jun 30, 2024 |
STATE STREET CORP | 0.17% | - | 26,152 | 7,300 | 38.72% | 29,552,000 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 1,305 | 1,305 | 100.00% | 1,475 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.05% | 0.00% | 7,389 | 1,120 | 17.87% | 8,350 | Jun 30, 2024 |
FAMILY FIRM, INC. | 0.01% | 0.00% | 1,000 | 1,000 | 100.00% | 1,130 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 182 | 182 | 100.00% | 206 | Jun 30, 2024 |
VANGUARD GROUP INC | 0.38% | - | 56,737 | - | - | 64,113 | Jun 30, 2024 |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.33% | - | 49,232 | - | - | 55,632 | Jun 30, 2024 |
AFFINITY CAPITAL ADVISORS, LLC | 0.09% | 0.00% | 13,279 | - | - | 15,005 | Jun 30, 2024 |
NIXON PEABODY TRUST CO | 0.65% | 0.01% | 97,165 | - | - | 109,796 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -69 | -100.00% | - | Jun 30, 2024 |
BLACKROCK INC. | 0.06% | - | 9,162 | -11,678 | -56.04% | 10,353 | Jun 30, 2024 |
As of Jun 30 2024, RenovoRx's largest institutional buyer is ADAR1 CAPITAL MANAGEMENT, LLC. The company purchased 355.24K stocks of RNXT, valued at $401.42K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BLACKROCK INC. | 0.06% | - | 9,162 | -11,678 | -56.04% | 10,353 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -69 | -100.00% | - | Jun 30, 2024 |
NIXON PEABODY TRUST CO | 0.65% | 0.01% | 97,165 | - | - | 109,796 | Jun 30, 2024 |
AFFINITY CAPITAL ADVISORS, LLC | 0.09% | 0.00% | 13,279 | - | - | 15,005 | Jun 30, 2024 |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.33% | - | 49,232 | - | - | 55,632 | Jun 30, 2024 |
VANGUARD GROUP INC | 0.38% | - | 56,737 | - | - | 64,113 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 182 | 182 | 100.00% | 206 | Jun 30, 2024 |
FAMILY FIRM, INC. | 0.01% | 0.00% | 1,000 | 1,000 | 100.00% | 1,130 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.05% | 0.00% | 7,389 | 1,120 | 17.87% | 8,350 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 1,305 | 1,305 | 100.00% | 1,475 | Jun 30, 2024 |
STATE STREET CORP | 0.17% | - | 26,152 | 7,300 | 38.72% | 29,552,000 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.07% | - | 10,000 | 10,000 | 100.00% | 11,300 | Jun 30, 2024 |
HRT FINANCIAL LP | 0.08% | 0.00% | 11,743 | 11,743 | 100.00% | 13,000 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.96% | - | 143,919 | 76,831 | 114.52% | 162,651 | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | 0.58% | - | 86,316 | 86,316 | 100.00% | 97,537 | Jun 30, 2024 |
ADAR1 CAPITAL MANAGEMENT, LLC | 2.38% | 0.08% | 355,240 | 355,240 | 100.00% | 401,421 | Jun 30, 2024 |
As of Jun 30 2024, RenovoRx's biggest institutional seller is BLACKROCK INC.. The company sold -11.68K shares of RNXT, valued at $10.35K.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ADAR1 CAPITAL MANAGEMENT, LLC | 2.38% | 0.08% | 355,240 | 355,240 | 100.00% | 401,421 | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | 0.58% | - | 86,316 | 86,316 | 100.00% | 97,537 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.07% | - | 10,000 | 10,000 | 100.00% | 11,300 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 1,305 | 1,305 | 100.00% | 1,475 | Jun 30, 2024 |
FAMILY FIRM, INC. | 0.01% | 0.00% | 1,000 | 1,000 | 100.00% | 1,130 | Jun 30, 2024 |
RenovoRx's largest new institutional shareholder by number of shares is ADAR1 CAPITAL MANAGEMENT, LLC, purchased 355.24K shares, valued at $401.42K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -69 | -100.00% | - | Jun 30, 2024 |
RenovoRx's largest sold out institutional shareholder by shares sold is WELLS FARGO & COMPANY/MN, sold -69.00 shares, valued at -, as of undefined.
RenovoRx Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
SCHWAB CAPITAL TRUST | 0.00% | 49,232 | - | - | Jan 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 65,177 | 11,087 | 20.50% | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 56,737 | -56,419 | -49.86% | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 910 | - | - | Jan 31, 2024 |
iSHARES TRUST | 0.00% | 20,840 | 5,700 | 37.65% | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 429 | - | - | Mar 31, 2024 |
RenovoRx's largest mutual fund holder by % of total assets is "SCHWAB CAPITAL TRUST", owning 49.23K shares, compromising 0.00% of its total assets.
RenovoRx Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 4 | -55.56% |
31 Mar, 24 | 9 | -18.18% |
31 Dec, 23 | 11 | -21.43% |
30 Sep, 23 | 14 | 55.56% |
30 Jun, 23 | 9 | -25.00% |
31 Mar, 23 | 12 | 9.09% |
31 Dec, 22 | 11 | -8.33% |
30 Sep, 22 | 12 | 33.33% |
30 Jun, 22 | 9 | -10.00% |
31 Mar, 22 | 10 | 42.86% |
31 Dec, 21 | 7 | -12.50% |
30 Sep, 21 | 8 | - |
As of 30 Jun 24, 4 institutions are holding RenovoRx's shares, representing a decrease of -55.56% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 252,084 | -23.50% |
31 Mar, 24 | 329,531 | -0.47% |
31 Dec, 23 | 331,078 | -8.95% |
30 Sep, 23 | 363,630 | 48.82% |
30 Jun, 23 | 244,336 | -88.83% |
31 Mar, 23 | 2,186,907 | 87.06% |
31 Dec, 22 | 1,169,112 | -1.52% |
30 Sep, 22 | 1,187,111 | -0.08% |
30 Jun, 22 | 1,188,008 | 621.19% |
31 Mar, 22 | 164,728 | 57.85% |
31 Dec, 21 | 104,357 | -38.30% |
30 Sep, 21 | 169,148 | - |
RenovoRx (RNXT) has 252.08K shares outstanding as of 30 Jun 24, down -23.50% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 1.69% | 17.76% |
31 Mar, 24 | 3.08% | 32.15% |
31 Dec, 23 | 3.10% | 26.59% |
30 Sep, 23 | 3.41% | 47.23% |
30 Jun, 23 | 2.69% | 0.46% |
31 Mar, 23 | 24.06% | 14.42% |
31 Dec, 22 | 12.92% | 7.54% |
30 Sep, 22 | 13.09% | 7.61% |
30 Jun, 22 | 13.12% | 390.87% |
31 Mar, 22 | 1.83% | 53.13% |
31 Dec, 21 | 1.86% | 20.50% |
30 Sep, 21 | 3.01% | - |
As of 30 Jun 24, RenovoRx is held by 1.69% institutional shareholders, representing a 17.76% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 3 | -25.00% |
31 Mar, 24 | 4 | -33.33% |
31 Dec, 23 | 6 | -25.00% |
30 Sep, 23 | 8 | 60.00% |
30 Jun, 23 | 5 | -37.50% |
31 Mar, 23 | 8 | 60.00% |
31 Dec, 22 | 5 | 25.00% |
30 Sep, 22 | 4 | -20.00% |
30 Jun, 22 | 5 | -44.44% |
31 Mar, 22 | 9 | 125.00% |
31 Dec, 21 | 4 | -50.00% |
30 Sep, 21 | 8 | - |
3 institutional shareholders have increased their position in RNXT stock as of 30 Jun 24 compared to 4 in the previous quarter (a -25.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | - | -100.00% |
31 Mar, 24 | 1 | - |
31 Dec, 23 | 1 | -50.00% |
30 Sep, 23 | 2 | - |
30 Jun, 23 | - | -100.00% |
31 Mar, 23 | 3 | - |
31 Dec, 22 | 3 | -25.00% |
30 Sep, 22 | 4 | 100.00% |
30 Jun, 22 | 2 | - |
31 Mar, 22 | - | -100.00% |
31 Dec, 21 | 2 | - |
30 Sep, 21 | - | - |
- institutional shareholders have reduced their position in RNXT stock as of 30 Jun 24 compared to 1 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 4 | -55.56% | 252,084 | -23.50% | 1.69% | 17.76% | 3 | -25.00% | - | -100.00% |
31 Mar, 24 | 9 | -18.18% | 329,531 | -0.47% | 3.08% | 32.15% | 4 | -33.33% | 1 | - |
31 Dec, 23 | 11 | -21.43% | 331,078 | -8.95% | 3.10% | 26.59% | 6 | -25.00% | 1 | -50.00% |
30 Sep, 23 | 14 | 55.56% | 363,630 | 48.82% | 3.41% | 47.23% | 8 | 60.00% | 2 | - |
30 Jun, 23 | 9 | -25.00% | 244,336 | -88.83% | 2.69% | 0.46% | 5 | -37.50% | - | -100.00% |
31 Mar, 23 | 12 | 9.09% | 2,186,907 | 87.06% | 24.06% | 14.42% | 8 | 60.00% | 3 | - |
31 Dec, 22 | 11 | -8.33% | 1,169,112 | -1.52% | 12.92% | 7.54% | 5 | 25.00% | 3 | -25.00% |
30 Sep, 22 | 12 | 33.33% | 1,187,111 | -0.08% | 13.09% | 7.61% | 4 | -20.00% | 4 | 100.00% |
30 Jun, 22 | 9 | -10.00% | 1,188,008 | 621.19% | 13.12% | 390.87% | 5 | -44.44% | 2 | - |
31 Mar, 22 | 10 | 42.86% | 164,728 | 57.85% | 1.83% | 53.13% | 9 | 125.00% | - | -100.00% |
31 Dec, 21 | 7 | -12.50% | 104,357 | -38.30% | 1.86% | 20.50% | 4 | -50.00% | 2 | - |
30 Sep, 21 | 8 | - | 169,148 | - | 3.01% | - | 8 | - | - | - |
RenovoRx Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of RenovoRx's stock was made by Gentry Leesa on Mar 08 2024, selling 62,500 shares at $2.11 per share (valued at $131.88K). The last insider buy of RNXT was made by Agah Ramtin on Jan 30 2024, buying 40,983 shares at $1.22 per share (worth $50.00K).
RenovoRx Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | 18 | 3 | 600.00% |
Q4 2023 | 7 | - | - |
Q2 2023 | 1 | 2 | 50.00% |
Q1 2023 | 3 | 1 | 300.00% |
Q4 2022 | 5 | 1 | 500.00% |
Q3 2022 | 1 | 1 | 100.00% |
Q2 2022 | 2 | 1 | 200.00% |
Q1 2022 | 5 | 2 | 250.00% |
Q4 2021 | 5 | - | - |
Q3 2021 | 4 | 19 | 21.05% |
18 total buy trades, and 3 total sell trades (buy/sell ratio of 6.00%) were made by RenovoRx's insiders, as of Q1 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | 10 | - | - |
Q4 2023 | 2 | - | - |
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | - | - | - |
Q3 2022 | - | - | - |
Q2 2022 | 2 | - | - |
Q1 2022 | - | - | - |
Q4 2021 | - | - | - |
Q3 2021 | - | - | - |
As of Q1 2024, Insider owners conducted 10 open market buy trades and 0 open market sell trades of RenovoRx's stocks.
RenovoRx Peer Ownership
Ticker | Company |
---|---|
NTRB | Nutriband Inc. |
AXLA | Axcella Health Inc. |
MNPR | Monopar Therapeutics Inc. |
ADIL | Adial Pharmaceuticals, Inc. |
IKNA | Ikena Oncology, Inc. |
SABS | SAB Biotherapeutics, Inc. |
KTTA | Pasithea Therapeutics Corp. |
LGVN | Longeveron Inc. |
QNRX | Quoin Pharmaceuticals, Ltd. |
VRAX | Virax Biolabs Group Limited |
ELDN | Eledon Pharmaceuticals, Inc. |
TPST | Tempest Therapeutics, Inc. |
ANEB | Anebulo Pharmaceuticals, Inc. |
ABIO | ARCA biopharma, Inc. |
CBIO | Gyre Therapeutics, Inc. |
RNXT Ownership FAQ
Who Owns RenovoRx?
RenovoRx is owned by institutional shareholders (1.69%), insiders (1.90%), and public (96.41%). The largest institutional shareholder of RenovoRx is ADAR1 CAPITAL MANAGEMENT, LLC (2.38% of total shares) and the top mutual fund owner is SCHWAB CAPITAL TRUST (0.00% of total shares).
Who are the major institutional shareholders of RenovoRx?
RenovoRx's major institutional shareholders are ADAR1 CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, NIXON PEABODY TRUST CO, MILLENNIUM MANAGEMENT LLC, and VANGUARD GROUP INC. The top five shareholders own together 4.95% of the company's share outstanding.
How many RenovoRx shareholders are there?
As of Jun 2024, there are 4 institutional shareholders of RenovoRx.
What percentage of RenovoRx is owned by ADAR1 CAPITAL MANAGEMENT, LLC?
ADAR1 CAPITAL MANAGEMENT, LLC owns 355.24K shares of RenovoRx, representing 2.38% of the company's total shares outstanding, valued at $401.42K (as of Jun 2024).
What percentage of RenovoRx is owned by GEODE CAPITAL MANAGEMENT, LLC?
As of Jun 2024, GEODE CAPITAL MANAGEMENT, LLC holds 143.92K shares of RenovoRx (RNXT), compromising 0.96% of the company, valued at $162.65K.
What percentage of RenovoRx is owned by NIXON PEABODY TRUST CO?
NIXON PEABODY TRUST CO is the third largest holder of RenovoRx. The company owns 97.16K of the company's shares outstanding (worth $109.8K).